10 min listen
Evaluating the Effectiveness of Bivalent COVID-19 Vaccines in Children and Adolescents
Evaluating the Effectiveness of Bivalent COVID-19 Vaccines in Children and Adolescents
ratings:
Length:
12 minutes
Released:
Feb 6, 2024
Format:
Podcast episode
Description
Bivalent mRNA COVID-19 vaccines were recommended for children and adolescents aged 5 to 17 years in the US, but were they effective? JAMA Associate Editor Tracy A. Lieu, MD, MPH, spoke with author Leora R. Feldstein, PhD, US Centers for Disease Control and Prevention, about the effectiveness of bivalent COVID-19 vaccines in children and adolescents. Related Content: Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing SARS-CoV-2 Infection in Children and Adolescents Aged 5 to 17 Years
Released:
Feb 6, 2024
Format:
Podcast episode
Titles in the series (100)
Understanding Depression and Distress Among Medical Students: Interview with Laura Weiss Roberts, MD, MA, author of Understanding Depression and Distress Among Medical Students by JAMA Author Interviews